Unknown

Dataset Information

0

Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study.

ABSTRACT:

SUBMITTER: Lora-Tamayo J 

PROVIDER: S-EPMC7877892 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients.
| S-EPMC7552959 | biostudies-literature
Unknown Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study.
| S-EPMC9067693 | biostudies-literature
Unknown Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study.
| S-EPMC8221239 | biostudies-literature
Unknown Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study.
| S-EPMC9012665 | biostudies-literature
Unknown Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.
| S-EPMC7255189 | biostudies-literature
Unknown An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results.
| S-EPMC9076583 | biostudies-literature
Unknown Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase.
| S-EPMC9943556 | biostudies-literature
Unknown A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
| S-EPMC7121492 | biostudies-literature
Unknown Consultation psychiatry in COVID-19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs.
| S-EPMC8014835 | biostudies-literature
Unknown Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment.
| S-EPMC7654234 | biostudies-literature